Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist
Contact+90 (538) 677 60 18

ASCO and Google Transform Oncology with the Launch of an AI Assistant

ASCO and Google Transform Oncology with the Launch of an AI Assistant
In this article

Modern oncology means not only fighting cancer, but also racing to keep up with information .

Oncologists face an increasing workload, mainly because of:

  1. More cancer cases at younger ages
  2. Longer survival after cancer
  3. Rapid growth in treatment options
  4. More patients per physician
  5. A wider range of diagnostic tools and greater data volume
  6. Digital bureaucracy and documentation demands
  7. Increasing patient participation in clinical trials
  8. Rising expectations from patients and families

Oncologists working in rural and resource-limited settings in particular must manage multiple cancer types and rapidly apply constantly updated knowledge.

To address these challenges, ASCO (the American Society of Clinical Oncology) and Google Cloud have taken a potentially revolutionary step through a new collaboration: they introduced ASCO Guidelines Assistant , an AI-powered clinical guideline assistant.


Lightning-Fast Access to Cancer Guidelines Through AI

This new digital assistant was developed using Google Cloud's advanced Vertex AI platform and Gemini models. Oncologists can now access all of ASCO's evidence-based clinical guidelines within seconds. Access is not only fast but interactive: physicians can ask questions, follow up, and easily incorporate the information into patient care plans.

The system currently operates only in English.

📌 An example scenario with 2 consecutive questions:

What is the current 2025 first-line treatment recommendation for metastatic HER2-negative breast cancer? ASCO Guidelines Assistant


Does this recommendation also apply to premenopausal patients? ASCO Guidelines Assistant example case, question 2


Why Does It Matter? In Clinical Practice, Time = Life

🔬 ASCO Guidelines Assistantis more than an information tool: it is a decision-support system with the speed and accuracy to directly affect patient outcomes. The platform's most important advantage is that it provides information based solely on ASCO's scientifically approved, published clinical guidelines. This makes it a much more reliable solution than AI tools of uncertain provenance commonly found online.

ASCO CEO Dr. Clifford Hudis describes the collaboration as follows:

“This partnership combines ASCO's trusted guideline knowledge with next-generation AI, enabling physicians to make rapid, evidence-based decisions.”


Data-Driven Medicine, Strengthened by Transparency

Another important feature is its strong commitment to transparency and source attribution . Every piece of information includes a clear reference to the ASCO guideline from which it was drawn. Users can therefore see where a recommendation comes from and consult the details when necessary.


Global Impact: An Assistant for Every Oncologist

Google Cloud CEO Thomas Kurian summarizes it this way:

“Think of this system as an assistant that never tires, keeps learning, and can analyze mountains of data within seconds. Our collaboration with ASCO will expand AI's contribution to cancer care worldwide.”

The system will also enable users who rely on Google Cloud in more than 200 countries to transform healthcare. It will be particularly valuable for clinicians with heavy workloads and those in countries with large patient populations .


Conclusion: A New Era in Clinical Decision Support

ASCO Guidelines Assistant marks a milestone for AI in oncology. Making information not only accessible but also understandable, trustworthy, and easy to integrate turns this digital assistant into a practical aid in medicine.

💡 All ASCO-member oncologists can access the new tool now:
🔗 asco.org/GA

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

ASCO and Google Transform Oncology with the Launch of an AI Assistant

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy